ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    Qualitative Assessment of Patient-Perceived Treatment Burden Following Cardiac Transplantation.

    K. Deininger,1 J. Reich,1 J. Hirsch,2 S. Graveline,2 A. Feist,2 J. LaFleur,3 S. Smith,4 A. Ambardekar,1 J. Lindenfeld,5 C. Aquilante.1

    1University of Colorado, Aurora, CO; 2University of California San Diego, La Jolla, CA; 3University of Utah, Salt Lake City, UT; 4University of Florida, Gainesville, FL; 5Vanderbilt University, Nashville, TN.

    Patient-perceived treatment burden (PPTB), i.e., “the work of being a patient,” following heart transplantation (HTx) can affect patients' experiences of care, sense of self-efficacy in…
  • 2016 American Transplant Congress

    Clostridium difficile Infection in Patients with a Continuous Flow, Durable Left Ventricular Assist Device.

    J. Glick Frasiolas, I. Li, H. Kim, D. Tsapepas.

    NewYork-Presbyterian Hospital, Columbia University, New York.

    Clostridium difficile infection (CDI) increases morbidity and mortality in hospitalized patients. Patients with a ventricular assist device (VAD) are exposed to known risk factors for…
  • 2016 American Transplant Congress

    Assessment of Postoperative Glycemic Control in Orthotopic Heart Transplant Recipients.

    J. Glick Frasiolas, J. Matthew, D. Tsapepas.

    NewYork-Presbyterian Hospital, Columbia University, New York.

    Hyperglycemia may occur after solid organ transplantation because of stress, immunosuppressants, and diabetes mellitus. Glycemic control has been shown to decrease morbidity and mortality in…
  • 2016 American Transplant Congress

    Prednisone Wean After Dual Heart and Kidney Transplantation: Is There a Risk?

    D. Chang, J. Patel, M. Kittleson, T. Aintablian, L. Czer, D. Ramzy, J. Kobashigawa.

    Cedars-Sinai Heart Institute, Los Angeles, CA.

    Background: Corticosteroids are the cornerstone of immunosuppressive therapy post transplant (Tx)but there are deleterious effects of long-term use. A protocol of corticosteroid weaning starting 6-12…
  • 2016 American Transplant Congress

    Liver Evaluation for Heart Transplantation: Which Is Better, Noninvasive Scans or Liver Biopsy?

    R. Mohan, J. Patel, M. Kittleson, D. Chang, T. Aintablian, L. Czer, F. Esmailian, J. Kobashigawa.

    Cedars-Sinai Heart Institute, Los Angeles, CA.

    Background: Patients awaiting heart transplantation who have known liver disease from congestive hepatopathy are at increased risk for mortality post-transplantation. The evaluation of the liver…
  • 2016 American Transplant Congress

    Four-Factor Prothrombin Complex Concentrate as a Strategy to Rapidly Reverse Anticoagulation in Patients Undergoing Cardiac Transplantation: Better Than the Conventional Approach?

    T. Sam,1 G. Gonzalez-Stawinski,2 G. Saracino,3 A. Jamil,3 S. Hall,2 K. Cox,1 B. Lima.2

    1Department of Pharmacy, Baylor University Medical Center, Dallas, TX; 2Heart Transplantation and Mechanical Circulatory Support, Baylor University Medical Center, Dallas, TX; 3Baylor Research Institute, Baylor University Medical Center, Dallas, TX.

    PurposeThe purpose of this analysis is to compare outcomes of administering four-factor prothrombin complex concentrate (4F-PCC, Kcentra™) versus standard of care for anticoagulation reversal in…
  • 2016 American Transplant Congress

    Comparison of Actual versus Goal Tacrolimus Levels Post Cardiothoracic Transplant.

    E. Milas, I. Feurer, C. Truscott, J. Gray, N. Wilson, S. Bala, T. Dreher, M. Wigger, M. Steele, A. Shah, E. Lambright, D. Hanto.

    Vanderbilt Transplant Center, Nashville, TN.

    BackgroundAlthough target tacrolimus (TAC) trough levels necessary to prevent rejection are established post heart/lung transplant (tx), there is little published literature on the proportion of…
  • 2016 American Transplant Congress

    Using Gastrointestinal Biopsy to Predict Outcome in Patients Evaluated for Cardiac Transplantation for Amyloidosis: A Report from the International Consortium on Cardiac Amyloidosis Transplantation (iCCAT).

    Y. Li,1 K. Verkouw,1 S. Tabtabai,1 R. Barrios,2 R. Gill,3 J. Koo,4 C. Marboe,5 E. Rodriguez,6 C. Tan,6 T. De Marco,3 J. Estep,2 M. Hanna,6 M. Maurer,5 J. Patel,4 V. Selby,3 M. Semigran,1 J. Stone.1

    1Massachusetts General Hospital, Boston, MA; 2The Methodist Hospital, Houston, TX; 3University of California San Francisco, San Francisco, CA; 4Cedars-Sinai Heart Institute, Los Angeles, CA; 5Columbia University Medical Center, New York, NY; 6Cleveland Clinic, Cleveland, OH.

    Heart transplant (HT) is an established therapy for heart failure due to amyloidosis. The utility of gastrointestinal (GI) biopsy in predicting patient outcomes and guiding…
  • 2016 American Transplant Congress

    Medicaid Insurance Is Associated with Shorter Time to Transplant Listing After LVAD Implantation.

    W. Schultz, M. Yin, Y.-A. Ko, J. Vega, A. Morris.

    Emory University School of Medicine, Atlanta, GA.

    Introduction: Left-ventricular assist devices (LVAD) and total artificial hearts (TAH) are being increasingly utilized as a bridge to heart transplant (HT). Prior studies have demonstrated…
  • 2016 American Transplant Congress

    Air Pollution – An Additional Risk Factor for Developing Cardiac Allograft Vasculopathy.

    C. Bara, D. Böthig, Y. Scheibner, D. Bobylev, B. Przybylek, A. Haverich.

    Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.

    Purpose:Cardiac allograft vasculopathy (CAV) remains one of the primary causes of death in long-term follow-up after heart transplantation (HTx) and is the most limiting factor…
  • « Previous Page
  • 1
  • …
  • 1220
  • 1221
  • 1222
  • 1223
  • 1224
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences